[Remarks on the drug prevention of malaria].
D000328:Adult; D000962:Antimalarials / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D002738:Chloroquine / Q000627:therapeutic use; D004334:Drug Administration Schedule; D004338:Drug Combinations / Q000627:therapeutic use; D004351:Drug Resistance; D005260:Female; D006801:Humans; D008288:Malaria / Q000517:prevention & control*; D010961:Plasmodium / Q000187:drug effects; D011247:Pregnancy; D011248:Pregnancy Complications / Q000517:prevention & control; D011739:Pyrimethamine / Q000627:therapeutic use; D013413:Sulfadoxine / Q000627:therapeutic use; D014195:Travel
D000962:Antimalarials; D004338:Drug Combinations; C001205:fanasil, pyrimethamine drug combination; D013413:Sulfadoxine; D002738:Chloroquine; D011739:Pyrimethamine
Bemerkungen zur medikamentösen Malariaprophylaxe.